109 related articles for article (PubMed ID: 455693)
1. Provisional recommendation (1978) on evaluation of diagnostic kits. Part 1. Recommendation for specifications of labelling of clinical laboratory materials (Stage 2, Draft 1).
Rubin M; Barnett RN; Bayse D; Beutler E; Brown SS; Logan JE; Reimer CB; Westgard JO; Wilding P
Clin Chem; 1979 Aug; 25(8):1499-502. PubMed ID: 455693
[No Abstract] [Full Text] [Related]
2. Revised recommendation (1983) on evaluation of diagnostic kits. Part 1. Recommendations for specifications on labelling of clinical laboratory materials. International Federation of Clinical Chemistry.
Logan JE
Clin Chim Acta; 1984 Mar; 137(3):371F-379F. PubMed ID: 6697538
[No Abstract] [Full Text] [Related]
3. Provisional recommendation (1978) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits (Stage 2, Draft1).
Rubin M; Barnett RN; Bayse D; Beutler E; Brown SS; Logan JE; Reimer CB; Westgard JO; Wilding P
Clin Chem; 1979 Aug; 25(8):1503-5. PubMed ID: 455694
[No Abstract] [Full Text] [Related]
4. Revised recommendation (1983) on evaluation of diagnostic kits. Part 1. Recommendations for specifications on labelling of clinical laboratory materials.
Logan JE
J Clin Chem Clin Biochem; 1983 Dec; 21(12):893-8. PubMed ID: 6663249
[No Abstract] [Full Text] [Related]
5. Assessment of package inserts for diagnostic kits.
Secchiero S; Sciacovelli L; Bonvicini P; Zaninotto M; Plebani M
Clin Chem Lab Med; 1999 Jun; 37(6):663-5. PubMed ID: 10475075
[TBL] [Abstract][Full Text] [Related]
6. Guiding principles and recommendations on labelling of clinical laboratory materials: a WHO memorandum.
Bull World Health Organ; 1978; 56(6):881-5. PubMed ID: 310730
[TBL] [Abstract][Full Text] [Related]
7. Labelling deficiencies in test kits for the detection of antibodies to rubella.
Katz L; Hinberg IH; Weber F
Clin Biochem; 1979 Aug; 12(4):146. PubMed ID: 487565
[No Abstract] [Full Text] [Related]
8. Revised recommendation (1983) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits.
Logan JE
J Clin Chem Clin Biochem; 1983 Dec; 21(12):899-902. PubMed ID: 6663250
[TBL] [Abstract][Full Text] [Related]
9. Coping with the IVD directive.
Gower G
Med Device Technol; 2000 Oct; 11(8):28-9. PubMed ID: 11185185
[TBL] [Abstract][Full Text] [Related]
10. Revised recommendation (1983) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits. International Federation of Clinical Chemistry.
Logan JE
Clin Chim Acta; 1984 Mar; 137(3):381F-386F. PubMed ID: 6697539
[No Abstract] [Full Text] [Related]
11. Regulatory challenges for in vitro diagnostics in a global environment.
Longwell A
Qual Assur; 1994 Jun; 3(2):167-77. PubMed ID: 7804632
[TBL] [Abstract][Full Text] [Related]
12. Expiry-date tampering.
Watt G
Lancet; 2004 Jan; 363(9403):172. PubMed ID: 14726190
[No Abstract] [Full Text] [Related]
13. "Home brew" laboratory tests.
Kisner HJ
Clin Lab Manage Rev; 1999; 13(2):104-6. PubMed ID: 10557868
[No Abstract] [Full Text] [Related]
14. FDA issues final rule for classification and reclassification of immunochemistry reagents and kits.
Taylor CR
Am J Clin Pathol; 1999 Apr; 111(4):443-4. PubMed ID: 10191763
[No Abstract] [Full Text] [Related]
15. Keeping waived tests simple.
Clin Leadersh Manag Rev; 2004; 18(1):65-9. PubMed ID: 14968759
[TBL] [Abstract][Full Text] [Related]
16. Expiry-date tampering.
Day JN; Hien TT; Farrar J
Lancet; 2004 Jan; 363(9403):172. PubMed ID: 14726189
[No Abstract] [Full Text] [Related]
17. From the Food and Drug Administration.
Nightingale SL
JAMA; 1996 Jul; 276(1):14. PubMed ID: 8667525
[No Abstract] [Full Text] [Related]
18. The International Federation of Clinical Chemistry. IFCC Section no. 3. Provisional Recommendation on quality control in clinical chemistry. Part 1. General Principles and Terminology (Stage 2, Draft 2).
Saris NE
Z Klin Chem Klin Biochem; 1975 Nov; 13(11):523-31. PubMed ID: 1216959
[No Abstract] [Full Text] [Related]
19. Rapid Diagnostic Tests for Neglected Infectious Diseases: Case Study Highlights Need for Customer Awareness and Postmarket Surveillance.
Barbé B; Verdonck K; El-Safi S; Khanal B; Teav S; Lilo Kalo JR; Ravinetto R; Chappuis F; Boelaert M; Jacobs J
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0004655. PubMed ID: 27812099
[No Abstract] [Full Text] [Related]
20. In reply to: Limitations in using the EFLM WG-A/ISO approach for assessment of reagent lot variability.
Thelen MHM; van Schrojenstein Lantman M; Boursier G; Vanstapel F; Panteghini M
Clin Chem Lab Med; 2023 Oct; 61(11):e218-e220. PubMed ID: 37261942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
